|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/57 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Patento numeris | 3157548 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15741128.1 |
| Europos patento paraiškos padavimo data | 2015-06-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/063760 |
| Data | 2015-06-18 |
| (87) | Numeris | WO 2015/193457 |
| Data | 2015-12-23 |
| (30) | Numeris | Data | Šalis |
| 14172910 | 2014-06-18 | EP |
| (72) |
KLEINSCHNITZ, Christoph , DE
NOLTE, Marc , DE
SIRÉN, Anna-Leena , DE
ALBERT-WEISSENBERGER, Christiane , DE
HOPP-KRAEMER, Sarah , DE
|
| (73) |
CSL Behring GmbH ,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | THERAPY USING A FACTOR XII INHIBITOR IN A NEUROTRAUMATIC DISORDER |
| THERAPY USING A FACTOR XII INHIBITOR IN A NEUROTRAUMATIC DISORDER |